Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINITE CHB - stopping tenofovir after long-term suppression in HBeAg-negative chronic hepatitis B
2010-021925-12Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by Gilead Sciences. Primary endpoint: HBsAg loss at Week 144. Started Nov 2010; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2010-021925-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021925-12.